-
CEO Club: David Cordani joins as keynote speaker
The latest CEO Club conversation centers around the importance of health in and out of the workplace.
-
Kevin Mandia Highlights Latest Chief Executives Club
CEO Kevin Mandia as keynote speaker at Chief Executives Club.
-
CEO Club: Niren Chaudhary
Niren Chaudhary, the Chairman of Panera Brands, is the latest keynote speaker for the Chief Executives Club at Boston College.
-
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024.
-
Chief Executives Club Welcomes Darren Woods of ExxonMobil
Darren Woods, CEO and Chairman of Exxon Mobil, is the featured speaker on November 1st at the Boston College Chief Executives Club.
-
Chief Executives Club
The Boston College CEO Club welcomes business leaders from around Boston to hear thought leaders on a variety of topics.
-
Boston College CEO Club Features Pfizer Chief
Pfizer Chairman and Chief Executive Officer Albert Bourla speaks to CVS Health President and CEO Karen Lynch,at the Boston College Chief Executives Club.
-
Tornado-damaged Pfizer plant in North Carolina restarts production
Pfizer had said most of the tornado damage was to a storage facility, rather than its medicine production area.
-
CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability
The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer’s Abrysvo, from September through January.
-
CDC recommends updated Covid shot for everyone ages 6 months and up
A panel of CDC advisers voted Tuesday to recommend updated Pfizer and Moderna coronavirus booster shots for everyone ages 6 months and up.
-
Tornado damages key Pfizer plant, sparking concerns of a drug shortage
A tornado has heavily damaged a major Pfizer pharmaceutical plant in North Carolina — the latest in a string of extreme weather events plaguing the U.S.
-
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This Summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.